Related Articles
p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.
An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer
Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer
Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast
Categorical meta-analysis of Osteopontin as a clinical cancer marker